Viewing Study NCT02116959


Ignite Creation Date: 2025-12-24 @ 2:58 PM
Ignite Modification Date: 2026-02-25 @ 8:48 PM
Study NCT ID: NCT02116959
Status: TERMINATED
Last Update Posted: 2020-04-16
First Post: 2014-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module